NCT07172360RecruitingPhase 3
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
A Multicenter, Randomized, Double-blind, Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Active Ankylosing Spondylitis
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 420 (estimated)
- First submitted
- 8 Sept 2025
- Start date
- 26 Dec 2025
- Primary completion date
- 30 Aug 2027
- Lead sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Diseases
- Ankylosing spondylitis
- NCT number
- NCT07172360
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 420
- From 26 Dec 2025 to the primary completion date, 30 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals who have undergone organ transplantation in the past and require continuous use of immunosuppressants.
Other illness
- Those who may be allergic to VC005, similar drugs or their excipients.
Other
- Those who, for any reason, are considered by the investigator to be unsuitable for participation in this study.
Who the study is looking for
- The subject understands and voluntarily signs the informed consent form (ICF) and is willing and able to comply with the study protocol;
- The subject is between 18 and 70 years of age (including borderline values) at the time of signing the ICF, regardless of gender;
- The subject has been diagnosed with AS according to the 1984 New York Revised Criteria for Ankylosing Spondylitis
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.